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Association of genetic polymorphisms of eNOS with glaucoma
Glaucoma,  an  irreversible  retinal  deterioration  which
results in progressive visual field loss along with decreased
contrast  and  color  sensitivity,  is  a  multifactorial  optic
neuropathy characterized by apoptotic cell death of the retinal
ganglion cells (RGCs) in the optic disc or retinal nerve fiber
[1,2]. Previous studies suggested that vascular dysregulation
play an important role in the etiology of glaucoma [3,4].
Recently,  activation  of  nitric  oxide  synthase  (NOS),  an
enzyme associated with the death of RGC caused by ischemic
injury,  has  been  reported  as  one  potential  mechanism  of
glaucomatous damage to the retina and optic nerve. Several
isoforms of NOS have been reported in abundance in almost
all layers of the retina, but the circulating NO is synthesized
solely in the vascular endothelium through the action of the
endothelial nitric oxide synthase (eNOS) on the substrate L-
arginine  [5].  Previous  studies  have  revealed  that
polymorphisms in the eNOS gene may alter eNOS expression
and thus cause a decrease in NO synthesis [3], which may
related to cardiovascular disease. Nevertheless, an abundance
of NOS also had been found in the optic nerve head vessels
of primary glaucoma patients, supporting the idea that the
optic  nerve  damage  in  glaucoma  can  be  related  to  eNOS
overexpression [6].
Recently, Ayub et al. [7] reported an association of an
eNOS  genetic  polymorphism  with  glaucoma  in  Pakistani
cohorts. But the relationship between eNOS polymorphisms
and glaucoma in Han Chinese is unclear. The present study
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was conducted to determine whether eNOS polymorphisms
were associated with POAG and PCAG in the Han Chinese
population.
METHODS
Subjects: The study followed the tenets of the Declaration of
Helsinki  with  written  informed  consent  obtained  from  all
patients or from their parents if their age was less than 18. The
patients  and  controls  were  randomly  selected  from  the
Affiliated  Xinqiao  Hospital  of  the  3rd  Military  Medical
College. The participants included 120 unaffected controls,
102 POAG patients, and 88 PCAG patients. The patients were
selected on the basis of their clinical history, cup-to-disc ratio
(CDR) evaluation, visual field evaluation, and elevated IOP,
and  categorized  into  POAG  and  PCAG  groups  based  on
gonioscopic  findings.  In  addition,  to  rule  out  any  ocular
anomaly,  the  controls  also  underwent  applanation
tonometery, slit lamp examination, CDR measurement and
visual field assessment.
Genotyping: There are 253 single nucleotide polymorphisms
(SNPs) for human eNOS listed in the National Center for
Biotechnology  Information  SNP  database.  It  has  been
observed that adjacent SNPs are often highly correlated. To
reduce  genotyping  cost,  many  algorithms  have  been
developed to select a smallest set of SNPs such that all the
other SNPs can be inferred from them. The selected SNPs are
called tag SNPs. As described on the website a tag SNP is a
representative  SNP  in  a  region  of  the  genome  with  high
linkage disequilibrium (the non-random association of alleles
at two or more loci). It is possible to identify genetic variation
without genotyping every SNP in a chromosomal region. Tag
SNPs are useful in whole-genome SNP association studies in
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Purpose: Several studies suggest that vascular dysregulation play a role in the etiology of glaucoma. In the present study,
we aimed to investigate the association of endothelial nitric oxide synthase (eNOS) gene polymorphisms with primary
open angle glaucoma (POAG) and primary closed angle glaucoma (PCAG).
Methods: There were 102 POAG and 88 PCAG patients, diagnosed on the basis of clinical history, raised intraocular
pressure (IOP), cup-to-disc ratio (CDR) and visual field defects, and 120 age- and sex-matched control subjects genotyped
for 5 tagging single nucleotide polymorphisms (SNPs; rs743507, rs3793342, rs11771443, rs7830, and rs3918188) of the
human eNOS gene.
Results: rs3793342, rs743507, rs11771443, rs7830, and rs3918188 were not found to be associated with POAG or with
PCAG. In the haplotype-based case-control analysis, the frequency of the C-T haplotype established by rs3793342 and
rs11771443  was  significantly  higher  for  POAG  patients  than  for  control  subjects  (p<0.001,  OR=5.111,
95%CI=1.766~14.788).
Conclusions: The C-T haplotype established by rs3793342 and rs11771443 may be genetic marks of POAG in the Han
Chinese population.which  hundreds  of  thousands  of  SNPs  across  the  entire
genome  are  genotyped.  For  this  reason,  the  International
HapMap Project hopes to use tag SNPs to discover genes
responsible for certain disorders. We selected the tag SNPs of
eNOS on the International HapMap Project website using
phase III database and analyzed these SNPs with Haploview
4.2  software.  We  obtained  five  tagging  SNPs  (rs743507,
rs3793342,  rs11771443,  rs7830,  and  rs3918188)  for  Han
Chinese  using  minor  allele  frequency  (MAF)  ≥0.05  and
linkage disequilibrium patterns with r2≥0.8 as a cutoff. As
shown  in  Figure  1,  these  five  SNPs  were  located  in  two
haplotype-blocks.
Genomic DNA was extracted from the peripheral blood
leukocytes using a DNA extraction Kit (Beijing Bioteke Co.
Ltd., Beijing, China). Quantification of extracted DNA was
performed using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE). Genotyping was
performed  using  the  TaqMan®  SNP  Genotyping  Assay
(Applied  Biosystems  Inc.,  Foster  City,  CA)  as  described
previously  [8,9].  Briefly,  The  TaqMan  SNP  Genotyping
Assays  were  performed  using  the  method  of  Taq
amplification. In the 5’nuclease assay, discrimination occurs
during the polymerase chain reaction (PCR) because of allele-
specific  fluorogenic  probes  that,  when  hybridized  to  the
template,  are  cleaved  by  the  5'  nuclease  activity  of  Taq
polymerase. The probes contain a 3' minor groove-binding
group (MGB) that hybridizes to single-stranded targets with
greater sequence-specificity than ordinary DNA probes. This
reduces nonspecific probe hybridization, and results in low
background  fluorescence  in  the  5'  nuclease  PCR  assay.
Cleavage results in increased emission of a reporter dye. Each
5' nuclease assay requires 2 unlabeled PCR primers and 2
allele-specific probes. Each probe is labeled with 2 reporter
dyes at the 5' end.  In the present study, VIC and FAM were
used as the reporter dyes. The primers and probes used in the
TaqMan® SNP Genotyping Assays (ABI) were chosen based
on  information  available  at  the  ABI  website.  PCR
amplification  was  performed  using  6  µl  of  TaqMan®
Universal Master Mix, No AmpErase® UNG (2×; ABI) in a
12 µl final reaction volume containing 2 ng of DNA, 0.22 µl
of  TaqMan®  SNP  Genotyping  Assay  Mix  (20×  or  40×),
primers at a concentration of 900 nmol/l each, and probes at
a final concentration of 200 nmol/l each. Thermal cycling
conditions were as follows: 50 °C for 2 min; 95 °C for 10 min;
40 cycles of 95 °C for 15 s; and 62 °C for 1 min. Thermal
cycling was performed using the GeneAmp 9700™ system.
Figure 1. Genetic variation in the human
eNOS gene. LD blocks across the locus
in Chinese Han. LD blocks derived by
solid spline method in Haploview. LD
value shown: r2*100; r2 color scheme:
r2=0:  white;  0<r2<1:  shades  of  gray;
r2=1: black.
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was tested for each polymorphism by the χ2 test. Allele or
genotype  frequencies  between  patients  and  controls  were
compared by the χ2 test or Fisher’s exact test. SPSS version
15.0 software (SPSS Inc., Chicago, IL) was used. Pairwise
linkage  disequilibrium  (LD)  estimation  and  expectation-
maximization  (EM)-based  haplotype  association  analysis
were  performed  using  Haploview  4.2  [10]  and  SHEsis
software [11,12]. In the haplotype-based case control analysis,
haplotypes with a frequency of <0.03 were excluded. The
frequency distribution of the haplotypes was calculated by
performing a permutation test using the bootstrap method. In
addition,  logistic  regression  analysis  was  performed  to
calculate the OR value and its 95% confidence interval. To
analysis the association of these five SNPs with POAG and
PCAG, three models were presented such as the general model
(common allele homozygotes coded as 1, heterozygotes as 2,
and  recessive  allele  homozygotes  as  3),  the  dominant
(common allele homozygotes coded as 1 and heterozygotes
and  recessive  allele  homozygotesas  2),  and  the  recessive
model (common allele homozygotes and heterozygotes coded
as 1 and recessive allele homozygotes as 2). To assess the
association of each SNP with POAG and PCAG, we used a
Bonferroni correction to control for the number of variants
tested;  this  was  5,  so  the  probability  value,  0.01,  was
considered to be significant.
RESULTS
The characteristics of the 310 study participants were shown
in Table 1. Patients with POAG and PCAG and the controls
were genotyped for five tagging SNPs of eNOS. Neither the
genotype  nor  the  allele  frequencies  of  these  5  SNPs  was
significantly different between the control and the POAG
patients (all p>0.01). There were not significant difference
between the control subjects and the POAG/PCAG patients
not only in the dominate model but also in the recessive model
(all p>0.01; Table 2).
In the haplotype-based case-control analysis, for these
five  tagging  SNPs  located  on  two  haplotype  blocks,
respectively, rs3793342 and rs11771443 located in block one
and rs743507 and rs7830 located block two, but rs3918188
was not located in these two blocks (Figure 1). Haplotypes
were established through the use of 4 SNPs (rs3793342 and
rs11771443 in the block one; rs743507 and rs7830 in the block
two; Table 3). The frequency of the C-T haplotype established
by rs3793342 and rs11771443 was significantly higher for
POAG patients than for control subjects (p<0.001, OR=5.111,
95%CI=1.766~14.788).  However,  the  frequency  of  other
haplotypes  were  not  significantly  different  between  the
control subjects and the POAG/PCAG patients (all p>0.01).
Limitations of this study: The present study was limited
by the relatively small sample size. This may have led to weak
statistical significance and wide CIs when estimating odds
ratios.
DISCUSSION
The main findings in the present study were the C-T haplotype
established by rs3793342 and rs11771443 may be genetic
marks of POAG in the Han Chinese population.
The foundation for human studies examining putative
causative genes that may be involved in glaucoma is based on
a  candidate  gene  approach.  This  involves  selecting  a
functionally  relevant  gene  to  study  and  subsequently
investigating its association with the glaucoma. The genes for
eNOS present candidates for glaucoma because it is the gene
encoding one important factor-eNOS, which is involved in
different processes, like neurotransmission, the regulation of
vascular tone, vasodilatation and apoptosis. In addition, it also
regulates  blood  flow  to  the  ocular  tissues  and  has  been
implicated in the pathogenesis of cardiovascular diseases and
different  neurodegenerative  disorders,  such  as  diabetic
retinopathy [13], glaucoma [14], and migraines [15]. And its
downstream  product-Nitric  Oxide  (NO)  is  responsible  for
maintaining arteries’ vasodilation, which keeps the ocular
blood  flow  constant.  When  the  endothelial  function  is
deregulated,  the  blood  supply  to  the  tissue  is  altered  and
impaired blood flow damages the optic nerve and leads to the
development of glaucomatous changes in the optic nerve,
which then results in an increase in the CDR. Liu et al. [16]
demonstrated that RGC degeneration in the glaucomatous
optic nerve head of POAG patients clearly corresponds to
excess  plasma  NO-mediated  neurotoxicity.  However,  the
authors  did  not  conduct  any  genetic  studies  to  find  the
susceptible loci.
TABLE 1. CHARACTERISTICS OF STUDY PARTICIPANTS.
Group POAG PCAG Controls
Number of subjects 102 88 120
Age at diagnosis (years) 59.1±17.3 60.7±14.7 65.6±16.4
Sex (M/F) 82/20 70/18 91/29
Highest IOP (mmHg) 24.3±8.2 28.5±8.8 15.6±3.2
Vertical cup-disc ratio 0.81±0.10 0.85±0.09 0.41±0.07
Note: 1 mmHg=0.133 kPa; For controls, age at diagnosis refers to age at inclusion.
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genetic  polymorphisms  of  eNOS  that  enhances  eNOS
expression would contribute to NO mediated toxicity. The
previously study [17] indicated that a 27-bp variable number
of  tandem  repeat  (VNTR)  polymorphism  in  intron  4  of
eNOS  significantly  influences  plasma  NO  levels.
Furthermore, Ayub and his colleagues [7] also found this
VNTR polymorphism was associated with both POAG and
PCAG in Pakistani cohorts. And Sakai et al. [18] found the
T-786C polymorphism of eNOS to be a risk factor of non-
arteritic anterior ischemic optic neuropathy (NAION) disease.
However, Logan et al. [19] were unable to show a significant
association between eNOS polymorphism T-786C and VNTR
repeat polymorphism and glaucoma. Similarly, Sena et al.




(n=102) p# (χ2) OR (95% CI)
PCAG
(n=88) p (χ2) OR (95% CI)
rs743507
Genotypes
AA 81 (0.675) 70 (0.686) 0.263 (2.675) 0.205 (0.023–1.872)
p=0.122*
62 (0.705) 0.570 (1.223) 0.361 (0.032–4.405)
p=0.390*
AG 38 (0.317) 28 (0.275)     24 (0.273)    
GG 1 (0.008) 4 (0.039)   1.053 (0.598–1.856)
p=0.858**
2 (0.023)   1.148 (0.632–2.084)
p=0.650**
Alleles
A 0.833 0.822 0.785 (0.074) 0.933 (0.569–1.531) 0.841 0.836 (0.043) 1.057 (0.624–1.792)
G 0.167 0.178     0.159    
rs3793342
Genotypes
CC 91 (0.758) 66 (0.647) 0.045 (6.203) 7.435 (0.880–62.839)
p=0.032*
60 (0.682) 0.388 (1.893) 0.361 (0.032–4.405)
p=0.390*
CT 28 (0.233) 30 (0.294)     26 (0.295)    
TT 1 (0.008) 6 (0.059)   1.712 (0.956–3.067)
p=0.069**
2 (0.023)   1.494 (0.370–1.261)
p=0.222**
Alleles
C 0.875 0.794 0.021 (5.310) 1.814 (1.088–3.030) 0.830 0.192 (0.695) 0.695 (0.401–1.203)




CC 30 (0.250) 27 (0.265) 0.952 (0.085) 0.982(0.531–1.816)
p=0.953*
23 (0.261) 0.965 (0.071) 1.084 (0.565–2.077)
p=0.809*
CT 61 (0.508) 50 (0.490)     45 (0.511)    
TT 29 (0.242) 25 (0.245)   1.080 (0.591–1.975)
p=0.802**
20 (0.227)   1.062 (0.565–1.993)
p=0.853**
Alleles
C 0.504 0.510 0.906 (0.014) 1.023 (0.704–1.486) 0.517 0.795 (0.067) 1.053 (0.713–1.554)
T 0.496 0.490     0.483    
rs7830
Genotypes
AA 23 (0.192) 18 (0.176) 0.922 (0.163) 0.901(0.507–1.560)
p=0.721*
16 (0.182) 0.967 (0.068) 0.930 (0.510–1.695)
p=0.813*
AC 62 (0.517) 52 (0.510)     45 (0.511)    
CC 35 (0.292) 32 (0.314)   0.904 (0.457–1.788)
p=0.771**
27 (0.307)   0.937 (0.462–1.900)
p=0.857**
Alleles
A 0.450 0.431 0.694 (0.155) 0.927 (0.634–1.135) 0.438 0.780 (0.064) 0.951 (0.643–1.406)
C 0.550 0.569     0.562    
rs3918188
Genotypes
AA 5 (0.042) 4 (0.039) 0.965 (0.071) 1.065 (0.278–4.076)
p=0.926*
4 (0.045) 0.942 (0.119) 0.913 (0.238–3.503)
p=0.894*
AC 45 (0.375) 40 (0.392)     31 (0.352)    
CC 70 (0.583) 58 (0.569)   0.941 (0.552–1.606)
p=0.825**
53 (0.602)   1.082 (0.618–1.894)
p=0.784**
Alleles
A 0.229 0.235 0.879 (0.023) 1.035 (0.665–1.610) 0.222 0.855 (0.033) 0.958 (0.601–1.526)
C 0.771 0.765     0.778    
        
*p: indicated the P value in dominate model; **p: indicated the p value in recessive model, #p: indicated the p value in general
        model.
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156[20] and Lin et al. [21] did not find any association between
POAG and eNOS intron 4 VNTR. Nevertheless, their studies
were based on single SNP analysis rather than haplotypes
approach.  Morris  et  al.  [22]  reported  that  for  genes  with
multiple susceptibilities, analysis based on haplotypes has
advantages over analysis based on individual SNP.
In  the  present  study,  we  genotyped  5  SNPs  in  Han
Chinese  subjects,  and  assessed  the  association  between
eNOS and glaucoma using a haplotype-based case-control
analysis based on the tagging SNP approach. We found the
the  frequency  of  the  C-T  haplotype  established  by
rs3793342  and  rs11771443  was  significantly  higher  for
POAG patients than for control subjects. But we did not find
any association between PCAG and eNOS. This result was not
in line with Ayub et al. [7] who found an association of
eNOS with not only POAG but also PCAG. The reason for
this discrepancy is currently unclear, but may be due to, at
least in part, the different genetic background of ethnicities
under study.
Conclusion: Our study indicated that the C-T haplotype
established by rs3793342 and rs11771443 may be a genetic
mark of POAG in the Han Chinese population.
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